出处 发表于 2025-3-25 06:29:18

Submitted on: 01 March 2012.
Revised on: 22 June 2012.
Accepted on: 14 July 2012.

___________________HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Nomadic 发表于 2025-3-25 11:22:29

http://reply.papertrans.cn/2/113/11213/11213-22.png

MIRTH 发表于 2025-3-25 12:25:17

http://reply.papertrans.cn/2/113/11213/11213-23.png

triptans 发表于 2025-3-25 15:56:42

Submitted on: 09 October 2006.
Revised on: 18 November 2006.
Accepted on: 16 December 2006.

___________________HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

乏味 发表于 2025-3-25 22:07:15

Submitted on: 13 February 2003.
Revised on: 13 April 2003.
Accepted on: 24 April 2003.

___________________HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

COKE 发表于 2025-3-26 02:16:48

http://reply.papertrans.cn/2/113/11213/11213-26.png

极微小 发表于 2025-3-26 07:41:44

Submitted on: 18 January 2019.
Revised on: 24 February 2019.
Accepted on: 29 March 2019.

___________________HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Debrief 发表于 2025-3-26 10:07:41

Submitted on: 06 January 2006.
Revised on: 23 April 2006.
Accepted on: 18 June 2006.

___________________HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

合群 发表于 2025-3-26 12:44:49

http://reply.papertrans.cn/2/113/11213/11213-29.png

阻碍 发表于 2025-3-26 17:38:01

http://reply.papertrans.cn/2/113/11213/11213-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 2024/2025影响因子:2.563 (HEMATOL ONCOL CLIN N) (0889-8588). (ONCOLOGY)(肿